4.7 Article

Correlation of humoral immune responses to different SARS-CoV-2 antigens with virus neutralizing antibodies and symptomatic severity in a German COVID-19 cohort

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Immunology

Role of Immunoglobulin M and A Antibodies in the Neutralization of Severe Acute Respiratory Syndrome Coronavirus 2

Jeromine Klingler et al.

Summary: The study found that spike- and RBD-specific IgM, IgG1, and IgA1 were produced by all or nearly all individuals in convalescent plasma, with these immunoglobulins playing critical roles in neutralizing the virus.

JOURNAL OF INFECTIOUS DISEASES (2021)

Article Immunology

SARS-CoV-2 Seroprevalence Survey Estimates Are Affected by Anti-Nucleocapsid Antibody Decline

Shelly Bolotin et al.

Summary: The study revealed that as time passed, the concentration of antibodies in SARS-CoV-2 positive specimens decreased, while the concentration in negative specimens increased. The association between the two tests also decreased over time, indicating a decline in anti-nucleocapsid antibodies.

JOURNAL OF INFECTIOUS DISEASES (2021)

Article Multidisciplinary Sciences

Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection

Jennifer M. Dan et al.

Summary: Different components of immune memory to SARS-CoV-2 exhibit distinct kinetics, with antibodies and spike-specific memory B cells remaining relatively stable over 6 months, while CD4(+) T cells and CD8(+) T cells declining with a half-life of 3 to 5 months after infection.

SCIENCE (2021)

Article Cell Biology

IgA dominates the early neutralizing antibody response to SARS-CoV-2

Delphine Sterlin et al.

Summary: The study found that humoral immune responses to SARS-CoV-2 infection are dominated by IgA antibodies, with specific IgA plasmablasts rapidly expanding shortly after symptom onset and peaking in the third week of the disease. Virus-specific antibody responses include IgG, IgM, and IgA, with IgA playing a greater role in virus neutralization compared to IgG.

SCIENCE TRANSLATIONAL MEDICINE (2021)

Article Biochemical Research Methods

Comparative analyses of SARS-CoV-2 binding (IgG, IgM, IgA) and neutralizing antibodies from human serum samples

Livia Mazzini et al.

Summary: This study aimed to detect SARS-CoV-2-specific antibodies in human serum samples to predict population immunity, identify potential infectious individuals, and confirm the significant neutralizing effect of antibodies against the receptor-binding domain of the virus spike protein.

JOURNAL OF IMMUNOLOGICAL METHODS (2021)

Article Cell Biology

Major role of IgM in the neutralizing activity of convalescent plasma against SARS-CoV-2

Romain Gasser et al.

Summary: Depletion of immunoglobulin M is associated with the most substantial loss of virus neutralization, followed by immunoglobulin G. This finding may have implications for designing more effective antibody-based COVID-19 therapies and explaining the increased susceptibility of autoimmune patients receiving therapies that inhibit the production of immunoglobulin M (IgM).

CELL REPORTS (2021)

Article Infectious Diseases

Evaluation of a commercially-available surrogate virus neutralization test for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)

Emelissa J. Valcourt et al.

Summary: The study evaluated the sensitivity, specificity, and cross-reactivity of sVNT compared with PRNT for SARS-CoV-2 neutralizing antibodies, finding sVNT to be a high-throughput screening tool for evaluation prior to confirmatory PRNT testing.

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2021)

Article Immunology

Low serum neutralizing anti-SARS-CoV-2 S antibody levels in mildly affected COVID-19 convalescent patients revealed by two different detection methods

Berislav Bosnjak et al.

Summary: The study found that COVID-19 convalescent patients have neutralizing antibodies in their serum that can effectively block the entry of SARS-CoV-2 virus. The levels of these neutralizing antibodies are correlated with the duration and severity of clinical symptoms, but not with age. The sVNT test is simpler, faster, and more cost-effective compared to the pVNT test, making it valuable for assessing the prevalence of neutralizing antibodies and selecting potential plasma donors for successful passive antibody therapy.

CELLULAR & MOLECULAR IMMUNOLOGY (2021)

Editorial Material Medicine, General & Internal

A novel coronavirus outbreak of global health concern

Chen Wang et al.

LANCET (2020)

Article Biochemistry & Molecular Biology

Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein

Alexandra C. Walls et al.

Editorial Material Medicine, General & Internal

Clinical course and mortality risk of severe COVID-19

Paul Weiss et al.

LANCET (2020)

Article Biochemistry & Molecular Biology

A serological assay to detect SARS-CoV-2 seroconversion in humans

Fatima Amanat et al.

NATURE MEDICINE (2020)

Article Multidisciplinary Sciences

Convergent antibody responses to SARS-CoV-2 in convalescent individuals

Davide F. Robbiani et al.

NATURE (2020)

Article Multidisciplinary Sciences

Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike

Lihong Liu et al.

NATURE (2020)

Article Immunology

Validation and clinical evaluation of a SARS-CoV-2 surrogate virus neutralisation test (sVNT)

Benjamin Meyer et al.

EMERGING MICROBES & INFECTIONS (2020)

Article Medical Laboratory Technology

Differences of SARS-CoV-2 serological test performance between hospitalized and outpatient COVID-19 cases

Johannes Wolf et al.

CLINICA CHIMICA ACTA (2020)

Article Multidisciplinary Sciences

Robust neutralizing antibodies to SARS-CoV-2 infection persist for months

Ania Wajnberg et al.

SCIENCE (2020)

Review Biochemistry & Molecular Biology

A systematic review of SARS-CoV-2 vaccine candidates

Yetian Dong et al.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)

Article Biochemistry & Molecular Biology

Disease severity dictates SARS-CoV-2-specific neutralizing antibody responses in COVID-19

Xiangyu Chen et al.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)

Article Immunology

Dynamic surveillance of SARS-CoV-2 shedding and neutralizing antibody in children with COVID-19

Pengcheng Liu et al.

EMERGING MICROBES & INFECTIONS (2020)